Correspondence 0001213900-24-074346 from Virpax Pharmaceuticals, Inc. (VRPX) (CIK 0001708331)
Virpax Pharmaceuticals, Inc. (VRPX) (CIK 0001708331)
Date: Aug. 30, 2024 · CIK: 0001708331 · Accession: 0001213900-24-074346
AI Filing Summary & Sentiment
File numbers found in text: 333-281080
Show Raw Text
CORRESP
1
filename1.htm
August 30, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Doris Gama
Office of Life Sciences
Re:
Withdrawal of Acceleration Request
Virpax Pharmaceuticals, Inc.
Registration Statement on Form S-1 (No. 333-281080)
Ladies and Gentlemen:
On behalf of Virpax Pharmaceuticals, Inc. (the
“Company”), this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement
filed as correspondence via EDGAR on Monday, August 26, 2024.
The Company is no longer requesting that such Registration
Statement be declared effective at 5:00 p.m., Eastern Time, on Monday, August 26, 2024, and we hereby formally withdraw our request for
acceleration of the effective date.
Thank you for your assistance.
Very truly yours,
/s/ Ross D. Carmel
Ross D. Carmel
cc:
Gerald W. Bruce